Use of antibody against O-acetylated GD2 ganglioside to improve the therapeutic potential of drugs
US11697689B2 · kind B2 · utility
0Cited by
2References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 5, 2017 |
| Grant date | Jul 11, 2023 |
| Priority date | — |
| Expiry date | Sep 15, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/73
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a method for delivery of an anti-cancer agent into a cell expressing the OAcGD2 ganglioside by using an antibody recognizing the OAcGD2 ganglioside.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.